Mammaglobin-A (MamA) is a human breast cancer-associated antigen expressed in 40–80% of primary and metastatic breast cancers, thus making MamA a potential antigen to develop breast cancer specific vaccines [5,6,7,8,9]. The gene discussed is SCGB2A2; the disease is breast carcinoma.